News tagged with leukemia stem
Some leukemia patients may be able to safely stop treatment
(PhysOrg.com) -- New medical trials suggest some chronic leukemia patients who are in complete remission may be cured by the standard drug used to treat the condition and can safely discontinue its use.
Oct 21, 2010 |
4.2 / 5 (5) |
1
|
Experimental drug shows promise against brain, prostate cancers
An experimental drug currently being tested against breast and lung cancer shows promise in fighting the brain cancer glioblastoma and prostate cancer, researchers at UT Southwestern Medical Center have found in two preclinical ...
Jan 04, 2010 |
4.9 / 5 (8) |
2
|
Moving beyond embryonic stem cells: Encouragement on the horizon
For nearly two decades, the medical world and the American public have grappled with the lightning-rod topic of stem cells, in particular the controversy surrounding cells from human embryos. But when researchers four years ...
Jul 05, 2011 |
2 / 5 (1) |
1
|
Researchers parse the origins of hematopoietic stem cells
Researchers at the University of California, San Diego School of Medicine have identified a gene and a novel signaling pathway, both critical for making the first hematopoietic stem cells (HSCs) in developing ...
Jun 08, 2011 |
not rated yet |
0
|
Decoding cancer patients' genomes is powerful diagnostic tool
Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations ...
Apr 19, 2011 |
3 / 5 (1) |
0
|
Scientists bioengineer a protein to fight leukemia
Scientists at the Children's Center for Cancer and Blood Diseases and The Saban Research Institute of Children's Hospital Los Angeles today announced a breakthrough discovery in understanding how the body ...
Feb 18, 2011 |
5 / 5 (5) |
1
|
New evidence of stem cells' pivotal role in cancer shown
Leukemia patients whose cancers express higher levels of genes associated with cancer stem cells have a significantly poorer prognosis than patients with lower levels of the genes, say researchers at the Stanford University ...
Dec 21, 2010 |
5 / 5 (3) |
1
|
Targeting cell pathway may prevent relapse of leukemia
About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukemia (AML) will have a relapse. In recent years, doctors have come to believe that this is due to leukemia stem cells, endlessly ...
Mar 25, 2010 |
5 / 5 (1) |
0
|
Drug that modifies gene activity could help some older leukemia patients
Older patients with acute myeloid leukemia (AML) might benefit from a drug that reactivates genes that cancer cells turn off, according to research at Washington University School of Medicine in St. Louis and collaborating ...
Jan 12, 2010 |
not rated yet |
0
|
Researchers 'notch' a victory toward new kind of cancer drug
(PhysOrg.com) -- Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in ...
Nov 11, 2009 |
4 / 5 (4) |
1
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
(PhysOrg.com) -- Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, ...
Aug 24, 2009 |
not rated yet |
0
Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
The most comprehensive analysis yet of the genome of childhood acute myeloid leukemia (AML) found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps, according to new ...
Jul 27, 2009 |
not rated yet |
0
Controversial cancer stem cells offer new direction for treatment (w/ Video)
In a review in Science, a University of Rochester Medical Center researcher sorts out the controversy and promise around a dangerous subtype of cancer cells, known as cancer stem cells, which seem capable of res ...
Jun 25, 2009 |
5 / 5 (1) |
2
Stem cell protein offers a new cancer target
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
Jun 01, 2009 |
not rated yet |
0
Scientists identify key gene that protects against leukemia
Researchers have identified a gene that controls the rapid production and differentiation of the stem cells that produce all blood cell types -- a discovery that could eventually open the door to more streamlined ...
Apr 08, 2009 |
5 / 5 (2) |
0
